We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Subgroup Analyses Not a Tool to Prove Efficacy of a Drug
Subgroup Analyses Not a Tool to Prove Efficacy of a Drug
November 10, 2010
Subgroup, or post-hoc, analyses of clinical trial results can be useful, especially if planned prospectively, but sponsors cannot use them to prove efficacy, except in the rarest of exceptions, an FDA official says.